X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ALEMBIC LTD UNICHEM LAB/
ALEMBIC LTD
 
P/E (TTM) x 30.1 122.5 24.6% View Chart
P/BV x 3.2 4.6 69.7% View Chart
Dividend Yield % 0.6 0.2 242.9%  

Financials

 UNICHEM LAB   ALEMBIC LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
ALEMBIC LTD
Mar-16
UNICHEM LAB/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs33453 632.6%   
Low Rs17429 593.9%   
Sales per share (Unadj.) Rs146.94.7 3,112.8%  
Earnings per share (Unadj.) Rs11.98.8 135.6%  
Cash flow per share (Unadj.) Rs16.29.0 179.8%  
Dividends per share (Unadj.) Rs2.000.15 1,333.3%  
Dividend yield (eoy) %0.80.4 215.5%  
Book value per share (Unadj.) Rs105.127.7 379.1%  
Shares outstanding (eoy) m90.84267.03 34.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.78.7 19.9%   
Avg P/E ratio x21.44.7 456.4%  
P/CF ratio (eoy) x15.74.6 344.2%  
Price / Book Value ratio x2.41.5 163.2%  
Dividend payout %16.81.7 983.6%   
Avg Mkt Cap Rs m23,07310,962 210.5%   
No. of employees `0005.7NA-   
Total wages/salary Rs m2,558238 1,074.8%   
Avg. sales/employee Rs Th2,352.5NM-  
Avg. wages/employee Rs Th450.9NM-  
Avg. net profit/employee Rs Th190.4NM-  
INCOME DATA
Net Sales Rs m13,3461,260 1,058.9%  
Other income Rs m192264 72.7%   
Total revenues Rs m13,5381,524 888.2%   
Gross profit Rs m1,63983 1,979.5%  
Depreciation Rs m39061 635.2%   
Interest Rs m290 9,600.0%   
Profit before tax Rs m1,412285 495.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-42,096 -0.2%   
Extraordinary Inc (Exp) Rs m-35-32 109.6%   
Tax Rs m2936 4,798.4%   
Profit after tax Rs m1,0802,343 46.1%  
Gross profit margin %12.36.6 186.9%  
Effective tax rate %20.72.1 968.1%   
Net profit margin %8.1185.9 4.4%  
BALANCE SHEET DATA
Current assets Rs m5,9791,689 354.1%   
Current liabilities Rs m2,432486 500.2%   
Net working cap to sales %26.695.4 27.9%  
Current ratio x2.53.5 70.8%  
Inventory Days Days63217 29.1%  
Debtors Days Days6081 74.5%  
Net fixed assets Rs m6,4031,624 394.2%   
Share capital Rs m182534 34.0%   
"Free" reserves Rs m9,2935,960 155.9%   
Net worth Rs m9,5487,404 129.0%   
Long term debt Rs m230104 220.9%   
Total assets Rs m12,8438,010 160.3%  
Interest coverage x50.0950.7 5.3%   
Debt to equity ratio x00 171.3%  
Sales to assets ratio x1.00.2 660.5%   
Return on assets %8.629.3 29.5%  
Return on equity %11.331.6 35.8%  
Return on capital %14.331.3 45.8%  
Exports to sales %29.22.9 992.6%   
Imports to sales %6.328.9 22.0%   
Exports (fob) Rs m3,90037 10,511.1%   
Imports (cif) Rs m847364 232.8%   
Fx inflow Rs m4,35637 11,742.3%   
Fx outflow Rs m1,162365 318.5%   
Net fx Rs m3,194-328 -974.3%   
CASH FLOW
From Operations Rs m1,119346 323.8%  
From Investments Rs m-853-48 1,792.6%  
From Financial Activity Rs m-334-301 111.0%  
Net Cashflow Rs m-68-3 2,276.7%  

Share Holding

Indian Promoters % 50.1 64.0 78.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.2 7,550.0%  
FIIs % 3.0 9.7 30.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 26.1 121.5%  
Shareholders   20,176 54,701 36.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  FULFORD INDIA  DR. REDDYS LAB  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; PSU & Energy Stocks Decline(01:30 pm)

Indian share markets continued to trade in red during the noon session weak Asian markets. PSU stocks and energy stocks are witnessing majority of the selling activity.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 22, 2018 02:35 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS